[
  {
    "ts": null,
    "headline": "How Analyst Revisions Are Shaping the Evolving Story for Zimmer Biomet",
    "summary": "Zimmer Biomet Holdings has seen its consensus analyst price target decrease slightly from $104.84 to $102.92, reflecting a cautious reassessment among market watchers. While updated product launches and strategic moves such as the FNA acquisition inspire long-term optimism, recent quarterly results have prompted analysts to temper their near-term outlook. Stay with us to learn how these evolving expectations could shape the narrative for Zimmer Biomet going forward and discover ways to track...",
    "url": "https://finnhub.io/api/news?id=321b17ecb8b805dd9dca8b2fe3ec5e46a9f17ceaf5ad983f9fc01abe456b5366",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763871310,
      "headline": "How Analyst Revisions Are Shaping the Evolving Story for Zimmer Biomet",
      "id": 137587065,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet Holdings has seen its consensus analyst price target decrease slightly from $104.84 to $102.92, reflecting a cautious reassessment among market watchers. While updated product launches and strategic moves such as the FNA acquisition inspire long-term optimism, recent quarterly results have prompted analysts to temper their near-term outlook. Stay with us to learn how these evolving expectations could shape the narrative for Zimmer Biomet going forward and discover ways to track...",
      "url": "https://finnhub.io/api/news?id=321b17ecb8b805dd9dca8b2fe3ec5e46a9f17ceaf5ad983f9fc01abe456b5366"
    }
  }
]